Thomas McKearn
2013
In 2013, Thomas McKearn earned a total compensation of $1.4M as President of Research and Development at Onconova Therapeutics.
Compensation breakdown
| Bonus | $84,823 |
|---|---|
| Option Awards | $1,001,364 |
| Salary | $274,189 |
| Other | $4,008 |
| Total | $1,364,384 |
McKearn received $1M in option awards, accounting for 73% of the total pay in 2013.
McKearn also received $84.8K in bonus, $274.2K in salary and $4K in other compensation.
Rankings
In 2013, Thomas McKearn's compensation ranked 5,325th out of 12,286 executives tracked by ExecPay. In other words, McKearn earned more than 56.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,325 out of 12,286 | 57th |
Division Manufacturing | 1,844 out of 4,612 | 60th |
Major group Chemicals And Allied Products | 527 out of 1,462 | 64th |
Industry group Drugs | 377 out of 1,156 | 67th |
Industry Pharmaceutical Preparations | 302 out of 890 | 66th |
Source: SEC filing on April 29, 2015.
McKearn's colleagues
We found one more compensation record of an executive who worked with Thomas McKearn at Onconova Therapeutics in 2013.
2013
Ramesh Kumar
Onconova Therapeutics